Induction of the CXCL1 (KC) chemokine in mouse astrocytes by infection with the murine encephalomyelitis virus of Theiler

Virology

Volumn 358, Issue 1, 2007, Pages 98-108

  Rubio, Nazario ^a   Sanz Rodriguez, Francisco ^b  

^a INSTITUTO CAJAL   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Chemokines; Chemotaxis; Monocyte macrophages; Neutrophils; Viral infection

Indexed keywords

COMPLEMENTARY RNA; CXCL1 CHEMOKINE; CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN TISSUE; CELL HYBRIDIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HYBRIDIZATION; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; SPECIES DIFFERENCE; SPINAL CORD; VIRUS INFECTION;

ANIMALS; ASTROCYTES; BLOTTING, NORTHERN; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES, CXC; CULTURE MEDIA; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1ALPHA; INTERLEUKIN-8; MICE; MICE, INBRED STRAINS; MONOCYTES; MULTIPLE SCLEROSIS; NEUTROPHILS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; RNA; RNA, MESSENGER; SPINAL CORD; THEILOVIRUS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MURINAE; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 33846015430     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.08.003     Document Type: Article

References (44)

1. Asensio V.C., and Campbell I.L. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci. 22 (1999) 504-512
2. Aubagnac S., Brahic M., and Bureau J.F. Viral load and a locus on chromosome 11 affect the late clinical disease caused by Theiler's virus. J. Virol. 73 (1999) 7965-7971
3. Bajetto A., Bonavia R., Barbero S., and Schettini G. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochemistry. 82 (2002) 1311-1329
4. Beutler B., and Cerami A. Cachectin: more than a tumor necrosis factor. N. Engl. J. Med. 316 (1987) 379-385
5. Clatch R.J., Melvold R.D., Miller S.D., and Lipton H.L. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 135 (1985) 1408-1414
6. Clatch R.J., Lipton H.L., and Miller S.D. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J. Immunol. 136 (1986) 920-927
7. Cochran B.H., Reeffel A.C., and Stiles C.D. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33 (1983) 939-947
8. Dal Canto M.C., and Lipton H.L. Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am. J. Pathol. 106 (1982) 20-29
9. Dinarello C.A. Interleukin-1 (IL-1) and its biologically related cytokines. Adv. Immunol. 44 (1989) 153-205
10. Endlich B., Armstrong D., Brodsky J., Novotny M., and Hamilton T.A. Distinct temporal patterns of macrophage-inflammatory protein-2 and KC chemokine gene expression in surgical injury. J. Immunol. 168 (2002) 3586-3594
11. Fischer F.R., Luo Y., Santambrogio L., and Dorf M.E. RANTES-induced chemokine cascade in dendritic cells. J. Immunol 167 (2001) 1637-1643
12. Gerety S.J., Rundell K., Dal Canto M.C., and Miller S.D. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease: VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope. J. Immunol 152 (1994) 919-929
13. Godiska R., Chantry D., Dietsch G.N., and Gray P.W. Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 58 (1995) 167-176
14. 2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. J. Immunol. 168 (2002) 1372-1379
15. Heinrich J.N., and Bravo R. The orphan mouse receptor interleukin (IL)-8Rβ binds N51. J. Biol. Chem. 270 (1995) 4987-4989
16. Hoffman L., Fife B.T., Begolka W.S., Miller S.D., and Karpus W.J. Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease. J. NeuroVirol. 5 (1999) 635-642
17. Kishimoto T. The biology of interleukin-6. Blood 74 (1989) 1-10
18. Lee J., Cacalano G., Camerato T., Toy K., Moore M.W., and Wood W.I. Chemokine binding and activities mediated by the mouse IL-8 receptor. J. Immunol. 155 (1995) 2158-2164
19. Lipton H.L. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect. Immun. 11 (1975) 1147-1155
20. Lipton H.L., and Dal Canto M.C. Theiler's virus induced demyelination: prevention by immunosuppression. Science 192 (1976) 62-64
21. Lira S.A., Zalamea P., Heinrich J.N., Fuentes M.E., Carrasco D., Lewin A.C., Barton D.S., Durham S., and Bravo R. Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells. J. Exp. Med. 180 (1994) 2039-2048
22. Melvold R.W., Jokinen D.M., Knobler R.L., and Lipton H.L. Variations in genetic control of susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Differences between susceptible SJL/J and resistant BALB/c strains map near the T cell β-chain constant gene on chromosome 6. J. Immunol. 138 (1987) 1429-1433
23. Melvold R.W., Jokinen D.M., Miller S.D., Dal Canto M.C., and Lipton H.L. Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 64 (1990) 686-690
24. Omari K.M., John G., Lango R., and Raine C.S. Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia 53 (2005) 24-31
25. Oquendo P., Alberta J., Wen D.Z., Graycar J.L., Derynck R., and Stiles C.D. The platelet-derived growth factor-inducible KC gene encodes a secretory protein related to platelet alpha-granule proteins. J. Biol. Chem. 264 (1989) 4133-41337
26. Palma J.P., and Kim B.S. Induction of selected chemokines in glial cells infected with Theiler's virus. J. Neuroimmunol. 117 (2001) 166-170
27. Palma J.P., and Kim B.S. The scope and activation mechanisms of chemokine gene expression in primary astrocytes following infection with Theiler's virus. J. Neuroimmunol. 149 (2004) 121-129
28. Peña Rossi C., Cash E., Aubert C., and Coutinho A. Role of the humoral immune response in resistance to Theiler's virus infection. J. Virol. 65 (1991) 3895-3899
29. Roos R.P., Firestone S., Wollmann R., Variakojis D., and Arnason B.G.W. The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J. Neuroimmunol. 2 (1982) 223-234
30. Rubio N., and Cuesta A. Lack of cross-reaction between myelin basic proteins and putative demyelinating virus envelope proteins. Mol. Immunol. 26 (1989) 663-668
31. Rubio N., and Capa L. Differential IL-1 synthesis by astrocytes from Theiler's murine encephalomyelitis virus-susceptible and-resistant strains of mice. Cellular Immunol. 149 (1993) 237-347
32. Rubio N., Martin-Clemente B., and Lipton H.L. High-neurovirulence GDVII virus induces apoptosis in murine astrocytes through tumor necrosis factor (TNF)-receptor and TNF-related apoptosis induced ligand. Virology 311 (2003) 366-375
33. Rubio N., Sanz-Rodriguez F., and Lipton H.L. Theiler's virus induces the MIP-2 chemokine (CXCL2) in astrocytes from genetically susceptible but not from resistant mouse strains. Cellular Immunol. 239 (2006) 31-40
34. Ryseck R.P., MacDonald-Bravo H., Mattei M.G., and Bravo R. Cloning and sequences of a secretory protein induced by growth factors in mouse fibroblasts. Exp. Cell Res. 180 (1989) 266-275
35. Sabroe I., Jones E.C., Usher L.R., Whyte M.K., and Dower S.K. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J. Immunol. 168 (2002) 4701-4710
36. Sanz-Rodriguez F., Hidalgo A., and Teixido J. Chemokine stromal cell-derived factor-1α modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1. Blood 97 (2001) 346-351
37. Schall T.J. In: Thomson A. (Ed). The Cytokine Handbook. 2nd ed. (1994), Academic Press, New York 419
38. Sierra A., and Rubio N. Theiler's murine encephalomyelitis virus induces tumor necrosis factor-alpha in murine astrocyte cell cultures. Immunology 78 (1993) 399-404
39. Tani M., Fuentes M.E., Peterson J.W., Trapp B.D., Durham K., Loy J.K., Bravo R., Ransohoff R.M., and Lira S.A. Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. J. Clin. Invest. 98 (1996) 529-539
40. Theiler M. Spontaneous encephalomyelitis of mice, a new virus disease. J. Exp. Med. 65 (1937) 705-719
41. Trottier M., Schlitt B.P., Kung A.Y., and Lipton H.L. Transition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease. J. Virol. 78 (2004) 12480-12488
42. Tsai W.C., Strieter R.M., Wilkowski J.M., Bucknell K.A., Burdick M.D., Lira S.A., and Standiford T.J. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J. Immunol. 161 (1998) 2435-2440
43. Wiekowski M.T., Chen S.-C., Zalamea P., Wilburn B.P., Kinsley D.J., Sharif W.W., Jesen K.K., Hedrick J.A., Manfra D., and Lira S.A. Disruption of neutrophil migration in a conditional transgenic model: evidence for CXCR2 desensitization in vivo. J. Immunol. 167 (2001) 7102-7107
44. Zheng L., Calenoff M.A., and DalCanto M.C. Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination. J. Neuroimmunol. 118 (2001) 256-267